Lipitor Causing Diabetes in Women

Lipitor Increases Risk of Diabetes

Lipitor, by Pfizer Pharmaceuticals, is used to treat high cholesterol levels. It works by blocking a certain enzyme (HMG CoA) in the liver, stopping the production of LDL-cholesterol, or “bad” cholesterol.

Lipitor is part of a class of drugs known as statins, which are quite effective in lowering cholesterol levels, but are also known to significantly increase the risk of developing type II diabetes for post-menopausal women.

There are many complications associated with diabetes including heart attacks, stroke, liver damage, kidney failure and more. Diabetes can lead to decreased quality of life, costly medical bills, loss of wages and even death.

In 2012 the U.S. Food and Drug Administration mandated that Pfizer warn patients and healthcare providers about the increased risk of developing type II diabetes.

Many consider this precaution too little and too late, as Lipitor had already been on the market for 16 years.

Because Pfizer failed to inform the public about the dangers of this drug, several lawsuits have been filed against Pfizer’s Lipitor with success.

The Science is in: Lipitor is Dangerous

Well established scientific institutions have found that Lipitor significantly increases the risk of developing type II diabetes.

For example, Yunsheng Ma, MD, PhD, MPH, of the University of Massachusetts Medical School found that Lipitor increased the risk of diabetes by nearly 50% in post-menopausal women.

Over the past decade, supporting evidence has flooded medical journals such as the Lancet, Circulation, the American College of Cardiology, and more showing that Lipitor and other statins significantly increase the risk of developing type II diabetes in post-menpausal women, women who were otherwise at low risk for contracting the disease.

Although the numbers vary slightly from study to study, the bottom line is clear: Lipitor significantly increases the risk of diabetes, a serious and long-term medical condition.

The Case Against Lipitor

Pfizer did not make the increased risk of diabetes known publicly, and consequentially many Lipitor consumers have suffered severe adverse health effects.

If Pfizer had properly informed healthcare providers and patients about the risks associated with their drug, many would have opted a less risky form of treatment. Instead, patients were not given the information they needed to make informed decisions regarding their own healthcare.

When a pharmaceutical company chooses to put its interests first, before the health of consumers, the consequences can be devastating to individuals and their families.

If you feel that you may be eligible for compensation, contact us today. Consumer Claim Center of America is is a patient advocacy service. We will help you determine if you are entitled to a claim, assist throughout the claims process, and connect you with the right attorney.

We are representing women with a body mass index (BMI) of 32 and below, as these women are not typically at high risk for developing type II diabetes. BMI is a measurement that uses a person’s height and weight to determine if they are under weight, of a healthy weight, or overweight.

Contact us today at 1-800-499-6652 or fill out our online form. Please leave a name and contact number and expect a call within 24 hours.